MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding MAIA Biotechnology, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 17 | 20 | +3 |
| Shares | 1.47M | 1.39M | −76.3K (−5.2%) |
| Value | $4.15M | $2.75M | −$1.39M (−33.6%) |
New holders (7)
Institutions that held MAIA Biotechnology, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 39,057 | $77.3K | 0.00% |
| Susquehanna International Group, LLP | 11,649 | $23.1K | 0.00% |
| Advisor Group Holdings, Inc. | 7,450 | $14.8K | 0.00% |
| Royal Bank of Canada | 3,000 | $6.00K | 0.00% |
| MAI Capital Management | 675 | $1.34K | 0.00% |
| Bernard Wealth Management Corp. | 500 | $990 | 0.00% |
| Tucker Asset Management LLC | 341 | $675 | 0.00% |
Sold out (4)
Institutions that held MAIA Biotechnology, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Naviter Wealth, LLC | 22,168 | $62.3K |
| UBS Group AG | 16,685 | $46.9K |
| XTX Topco Ltd | 10,991 | $30.9K |
| Sunbelt Securities, Inc. | 100 | $281 |